BPA Call HT942524A0014-HT009026FG0110024
- Not listed
- The Defense Health Agency awarded a $34,164 firm fixed price Blanket Purchase Agreement (BPA) call to Integrated DNA Technologies, Inc. (IDT) for consumable reagents and test kits, with a completion date of May 21, 2025. The contract represents a call against IDT's existing $5 million BPA with the Defense Health Agency and does not utilize a set-aside designation. IDT, headquartered in Coralville, Iowa, is a leading manufacturer of specialized nucleic acid products including custom DNA and RNA...
- The Defense Health Agency awarded a $12,817.12 firm fixed price BPA call to Integrated DNA Technologies, Inc. (IDT) for oligo primer products, with a completion date of September 30, 2025. This award represents a call against IDT's existing $5 million Blanket Purchase Agreement with the Defense Health Agency, enabling the agency to procure specialized oligonucleotide and primer products for molecular biology applications. The contract was awarded without set-aside designation, reflecting IDT's...
- This federal contract award is for $5,040 and was issued to Integrated DNA Technologies, Inc. (IDT) by the Office of the Chief Operating Officer, a civilian agency. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price. IDT, a leading manufacturer and supplier of specialized nucleic acid products and services, will provide custom DNA and RNA oligonucleotides, gene fragments, next-generation sequencing products, primers, probes, reagents, and other molecular biology...
- This federal contract award was made by the Office of the Chief Operating Officer, a civilian agency, to Integrated DNA Technologies, Inc. (IDT), a leading manufacturer and supplier of specialized nucleic acid products and services to the U.S. federal government. The $3,360 firm fixed-price contract, awarded on January 22, 2015, is a Blanket Purchase Agreement (BPA) call with a completion date of January 30, 2015. IDT, a for-profit organization headquartered in Coralville, Iowa, has a strong...
- This is a $627,939.66 firm fixed-price definitive contract awarded by the Defense Health Agency to Integrated DNA Technologies, Inc. (IDT) for reagents and consumables, including adapter supplies, for the Walter Reed Army Institute of Research. The contract has an ultimate completion date of August 13, 2028 and was awarded on June 24, 2024. The contract was not set aside and IDT, a leading manufacturer and supplier of specialized nucleic acid products and services to the U.S. federal government,...
- This is a federal contract award made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Integrated DNA Technologies, Inc. (IDT). The contract is a Blanket Purchase Agreement (BPA) valued at up to $100,000,000 with a period of performance through August 31, 2025. It allows for the delivery of various biological, oligonucleotide synthesis, and related laboratory supplies and services to support multiple federal...
- The Pacific West Area, a civilian component of the federal government, awarded a $22,000 firm fixed price purchase order to Integrated DNA Technologies, Inc. (IDT) on July 22, 2019, with an ultimate completion date of September 27, 2019. IDT, headquartered in Coralville, Iowa, is a leading manufacturer of specialized nucleic acid products and services, including custom DNA and RNA oligonucleotides, gene fragments, sequencing products, primers, and probes. The award carried no set-aside...
- This is a firm fixed-price contract awarded by the National Heart Lung and Blood Institute, an agency of the Department of Health and Human Services, to Integrated DNA Technologies, Inc. (IDT) to provide oligonucleotides needed to support an antibody association study project. The $16,494.25 contract is a Blanket Purchase Agreement (BPA) call and does not utilize any set-aside designations, indicating IDT competed effectively in the open market. IDT is a leading manufacturer and supplier of...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) for $16,438.00 in lab supplies. IDT is a manufacturer of nucleic acid products, including custom DNA and RNA oligonucleotides, gene fragments, next generation sequencing products, primers, probes, reagents, and research materials. IDT has held a Federal Supply Schedule contract with the Department of Veterans Affairs valued at...
- This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The $4,480 contract, without a set-aside designation, is for the delivery of various products including custom DNA and RNA oligonucleotides, gene fragments, next-generation sequencing products, primers, probes, and other reagents for biomedical...
- HT942524A0014Blanket Purchase Agreement
- HT942524A0014-HT009026FG0110024BPA Call
The Defense Health Agency awarded a $22,559.04 firm fixed price BPA (Blanket Purchase Agreement) call to Integrated DNA Technologies, Inc. (IDT) on January 28, 2026, for supplies required for casework at a medical treatment facility. The contract is scheduled for completion by September 30, 2026, and will be performed in Coralville, Iowa. This award is issued under IDT's existing $5 million BPA with the Defense Health Agency, enabling the contractor to deliver specialized molecular biology products and reagents. No set-aside designation was applied to this procurement, allowing IDT to compete in the open market based on its established capabilities and pricing. IDT is a leading manufacturer and supplier of specialized nucleic acid products, custom DNA and RNA oligonucleotides, sequencing reagents, primers, and probes to the federal government. The company maintains an established track record of supporting critical research and medical applications across multiple federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Defense. IDT's expertise in molecular biology supplies and custom synthesis services positions it to effectively support the Defense Health Agency's medical treatment facility casework requirements through this BPA call arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.6k | 1/27/26 |